Lijuan Wang
- Cancer Research top 0.5%
- MicroRNA in disease regulation 25
- Cancer-related molecular mechanisms research 23
- Molecular Biology top 2%
- Circular RNAs in diseases 16
- RNA Research and Splicing 10
- Extracellular vesicles in disease 8
- Oncology top 5%
- Peptidase Inhibition and Analysis 10
- Immunology top 10%
- Physiology top 5%
-
- Medical Imaging Techniques and Applications 7
-
- Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities 6
- Journals
- Journal of Biological Chemistry (2 papers)Nature Communications (1 paper)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- ChinaUnited StatesSlovakia
In The Last Decade
Lijuan Wang
142 papers receiving 4.3k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Cancer Research 1.9k
- Molecular Biology 2.6k
- Oncology 968
- Immunology 372
- Physiology 77
Countries citing papers authored by Lijuan Wang
This map shows the geographic impact of Lijuan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lijuan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lijuan Wang more than expected).
Fields of papers citing papers by Lijuan Wang
This network shows the impact of papers produced by Lijuan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lijuan Wang. The network helps show where Lijuan Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lijuan Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 5 | |
| 4 | 2023 | 13 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 13 | |
| 8 | 2023 | 4 | |
| 9 | 2023 | 1 | |
| 10 | Comparison of 68Ga-FAPI and 18F-FDG PET/CT in the Evaluation of Advanced Lung Cancerbreakdown → | 2022 | 117 |
| 11 | circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancerbreakdown → | 2019 | 340 |
| 12 | 2019 | 20 | |
| 13 | 2018 | 16 | |
| 14 | 2018 | 37 | |
| 15 | Expression analysis of mir-1 and mir-133 in three developmental stages of goat skeletal muscle | 2015 | 2 |
| 16 | Tissue expression pattern analysis of microRNA (miR)-27b in the growth process of goat (Capra hircus). | 2013 | 1 |
| 17 | Expressions and clinical significances of E1AF,MMP-7 and uPA in non-small cell lung cancer | 2012 | 1 |
| 18 | 2011 | 10 | |
| 19 | Inoculation Technique and Screening Maize Germplasm Resistance to Fusarium Ear Rot | 2007 | 1 |
| 20 | Co-occlusion of Baculovirus Enhancin with Polyhedrin | 2003 | 1 |
About Lijuan Wang
Lijuan Wang is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 146 papers that have together received 4.4k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (25 papers), Cancer-related molecular mechanisms research (23 papers), Circular RNAs in diseases (16 papers), Peptidase Inhibition and Analysis (10 papers), RNA Research and Splicing (10 papers), Extracellular vesicles in disease (8 papers), Medical Imaging Techniques and Applications (7 papers) and Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (6 papers). The work is most often cited by research in Cancer Research (1.9k citations), Molecular Biology (2.6k citations) and Oncology (968 citations). Lijuan Wang has collaborated with scholars based in China, United States and Slovakia. Frequent co-authors include Qifeng Yang, Bing Chen, Wenjing Zhao, Ning Zhang, Shengjia Shi, Yiran Liang, Xiaojin Song, Yuting Sang, Ying Liu and Hanwen Zhang. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.